Poxel S.A. (LON: 0RA2)
London
· Delayed Price · Currency is GBP · Price in EUR
1.600
0.00 (0.00%)
Jul 11, 2022, 8:29 AM BST
Poxel Revenue
Poxel had revenue of 1.16M EUR in the half year ending June 30, 2024, with 1,300.00% growth. This brings the company's revenue in the last twelve months to 2.19M, up 41.53% year-over-year. In the year 2023, Poxel had annual revenue of 1.98M with 193.92% growth.
Revenue (ttm)
2.19M EUR
Revenue Growth
+41.53%
P/S Ratio
n/a
Revenue / Employee
364.67K EUR
Employees
6
Market Cap
14.05M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.98M | 1.31M | 193.92% |
Dec 31, 2022 | 674.00K | -12.72M | -94.97% |
Dec 31, 2021 | 13.40M | 6.59M | 96.84% |
Dec 31, 2020 | 6.81M | -19.75M | -74.37% |
Dec 31, 2019 | 26.56M | -35.82M | -57.43% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |